Tune in Friday at 6pm ET for a Facebook Live with Dr. Mary Pat Gallagher, a pediatric endocrinologist at NYU Langone Health. She will be covering COVID-19 and what it means for those living with type 1 diabetes (T1D).
Danielle was diagnosed with T1D 14 years ago. “Having this gorgeous Lokai to remind me to embrace the highs & lows of life (and T1D!) has been amazing. Plus $1 from each bracelet sold goes to #JDRF & their mission to improve MY life with #T1D.” @livelokai https://t.co/3q6vHwnQIn
It's never too early to shop for the holidays! Looking for the perfect gift? Be the “active” type with wearable fitness devices from @fitbit. Fitbit will generously donate 12% of the purchase price to #JDRF. Take a look at what they have to offer - https://t.co/4Cs5h5cV1C
Looking for the perfect gift (maybe for yourself!)? Be the “active” type with wearable fitness devices from @Garmin who generously donate 20% of the purchase price to JDRF. Get yours at https://t.co/gxErya1pNS
We’re pleased to report that President Trump signed the continuing resolution that provides a short-term, $21.5 mil extension of the Special Diabetes Program (SDP), & keeps the Federal government operating through Nov. 21. https://t.co/iOEuHd03vq
Today is the last day to support #T1D research at @AdvanceAutoParts! Stop by your neighborhood location today and pick up your JDRF paper sneaker! Social media is the best way to spread the word about this campaign, so please share own posts on social media as well.
"[JDRF & @BeyondType1] are different organizations, but we are all here for the same reason: To cure this disease and improve the lives of those living with #T1D today. Working together, we aim to get there faster” @aaronjkowalski, PhD, @JDRFceo: https://t.co/isH1MtIH4l #JDRFxBT1
This patch would provide nearly $21.5 million for critical #T1D research while Congress works to pass a longer-term SDP renewal, and an agreement on the Federal budget for this fiscal year. The President is expected to sign the resolution within the next few days.
The U.S. Senate just passed a short-term extension of the Special Diabetes Program (SDP) as part of a continuing resolution that would keep the Federal government operating through November 21.
Did you know that @marshalls has partnered with JDRF since 1994. Stop by your local Marshalls today, make a donation and take a photo with the staff! #T1D
The next action is for the U.S. Senate to consider the continuing resolution next week, & several steps remain to secure a full, multi-year renewal. We will need your help along the way! Stay active on social using #RenewSDP, sharing why this critical funding is important to you!
This week the U.S. House of Representatives took an important step in passing a short-term extension of the Special Diabetes Program as part of a continuing resolution that would keep the Federal government operating through Nov. 21, & provide nearly $21.5 mil for #T1D research.
The toll of type 1 diabetes (T1D) doesn’t stop at the
physical—it can affect us mentally and emotionally as well. JDRF has some great videos on our YouTube channel.
https://t.co/t9AO41vrkF
#JDRF#T1D#type1diabetes#curetreatprevent
This week, leading researchers from around the world will convene at #EASD2019. This year, more than 50 studies will be presented by JDRF-funded researchers who are working to find cures for #T1D improve the lives of those living with the disease. https://t.co/qoXdWTuvX8
To renew the Special Diabetes Program, there will be many additional steps in the process & we will need your help! Become an advocate, & encourage friends & family to do the same to receive timely updates & actions you can take. Join us today: https://t.co/ymofFYvDGi #RenewSDP
Earlier today @JDRF, @AmDiabetesAssn, the @TheEndoSociety and the @NIHB1
led and sent letters to House and Senate Leadership – signed by 22 other organizations – urging them to ensure funding for the SDP and SDPI continues without interruption. https://t.co/iOEuHd03vq
You can get all of the latest fashions at your local @marshalls and what’s more fashionable than a world without type 1 #diabetes? Donate at any local Marshalls before time runs out! #T1D
On Tuesday, the FDA approved the first pre-mixed, pre-filled liquid glucagon formulation for use with either a pre-filled syringe (GVOKE PFS) or an auto-injector (GVOKE HypoPenTM.) @XerisPharma created the product to treat severe hypoglycemia--a daily concern for people with T1D.